Cartalax Peptide Bioregulator Description
Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.
Peptide Information
| Property | Value |
|---|---|
| Peptide Sequence | Ala-Glu-Asp |
| Molecular Formula | C12H19N3O8 |
| Molecular Weight | 333.29 g/mol |
| PubChem CID | 87815447 |
| Synonyms | Ala-Glu-Asp, alanyl-glutamyl-aspartic acid, T-31 peptide, H-Ala-Glu-Asp-OH |
Cartalax Structure
Source: PubChem
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
